← Leaderboards
George A Alba
Massachusetts General Hospital
$391,336
Attributed
$391,336
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $247.5K · FY2017–25$250K$187.5K$125K$62.5K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$391,336 · 2
By mechanism
R21$247,500 · 1
F32$143,836 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Anand T.n. Kumar$7,313,344
- Anna Moore$29,133,166
- Steven M Greenberg$39,743,346
- Brian J Bacskai$26,389,294
- Deborah A Quinn$476,604
Others in their field
Other Emerging Leaders on “Sampling”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$181,167,581
- Beth Baseler · Leidos Biomedical Research, Inc.$105,136,677
- Scott Topper · Broad Institute, Inc.$77,958,806
- Paul F Gallagher · Woods Hole Oceanographic Institution$63,916,876
- Leonard Freedman · Leidos Biomedical Research, Inc.$60,323,945
- Dale Sandler · Social And Scientific Systems, Inc.$59,740,435
Research focus
SamplingBlood VesselsPlasmaThrombosisProteinsDifferential ExpressionIn SituPathogenesisPulmonary Artery StructureSpecimenBiologyProteomicsMortalityMolecularBlood PlateletsBloodArterioleBiometryArterial DisorderAnticoagulationConnective Tissue DiseasesChronicBiomedical Referral CenterCertification
Grant awards (3)
Early, non-invasive detection of pulmonary vascular dysfunction in acute respiratory distress syndrome$247,500
R21 · FY2025 · HL · contact PI
NEDD9 promotes thrombosis and vascular remodeling in chronic thromboembolic pulmonary hypertension$74,086
F32 · FY2018 · HL · contact PI
NEDD9 promotes thrombosis and vascular remodeling in chronic thromboembolic pulmonary hypertension$69,750
F32 · FY2017 · HL · contact PI